482 studies found for:    Open Studies | "Pancreatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
Conditions: Colorectal Cancer;   Cancer of Pancreas;   Pancreatic Neoplasm;   Malignant Neoplasm of Large Intestine;   Malignant Tumor of Colon;   Colon Carcinoma;   Cancer of Colon;   Pancreatic Cancer
Interventions: Drug: FOLFOX6;   Biological: EGFRBi armed ATC Infusions
22 Recruiting Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
Conditions: Pancreatic Carcinoma Non-resectable;   Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: nab-Paclitaxel
23 Unknown  Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers
Condition: Gallbladder Neoplasms and Pancreatic Neoplasms
Intervention: Radiation: Tomotherapy
24 Unknown  Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer;   Unresectable Pancreatic Cancer
Intervention: Radiation: stereotactic body radiotherapy
25 Recruiting Combination Chemotherapy With or Without Oregovomab Followed By Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer;   Stage III Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: leucovorin calcium;   Biological: oregovomab;   Drug: nelfinavir mesylate;   Radiation: stereotactic body radiation therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Drug: fluorouracil
26 Recruiting Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Conditions: Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Biological: ipilimumab;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
27 Recruiting Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: dasatinib;   Drug: erlotinib hydrochloride
28 Recruiting Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery
Conditions: Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Drug: metformin hydrochloride;   Other: pharmacological study
29 Recruiting Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
Conditions: Locally Advanced Pancreatic Cancer;   Metastatic Pancreatic Cancer
Interventions: Drug: NC-6004;   Drug: Gemcitabine
30 Recruiting Analgesia and Pancreatic Cancer Surgery
Condition: Pancreatic Neoplasms
Interventions: Procedure: Epidural patient controlled analgesia;   Drug: Intravenous patient controlled analgesia
31 Unknown  Expression of Inflammatory Proteins in Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Behavioral: Expression type
32 Recruiting Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Condition: Pancreatic Neoplasms
Interventions: Drug: Ascorbate;   Drug: Gemcitabine;   Radiation: Radiation therapy
33 Unknown  Three New Methods for Diagnosing Pancreas Cancer
Condition: Pancreas Cancer
Intervention: Procedure: Ultrasound and contrast agent
34 Recruiting Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: alisertib;   Drug: gemcitabine
35 Recruiting Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer
Condition: Pancreas Cancer
Intervention: Other: Palliative care with decision aids
36 Recruiting A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body
Condition: Pancreatic Neoplasms
Interventions: Drug: LY2157299;   Drug: Gemcitabine
37 Recruiting Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Stage I Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: irinotecan hydrochloride;   Drug: fluorouracil;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
38 Recruiting Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: dinaciclib;   Drug: Akt inhibitor MK2206;   Other: pharmacological study;   Other: laboratory biomarker analysis
39 Recruiting A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine
Condition: Pancreatic Cancer
Intervention: Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
40 Not yet recruiting Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer
Conditions: Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dovitinib lactate;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: pharmacological study;   Other: laboratory biomarker analysis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years